18LBA A GCIG randomized phase III study of carboplatin (C) & pegylated liposomal doxorubicin (PLD) (C-D) vs carboplatin (C) & paclitaxel (P) (C-P): CALYPSO results in partially platinum-sensitive ovarian cancer (OC) patients
- Resource Type
- Abstract
- Source
- In
EJC Supplements 2009 7(3):11-11 - Subject
- Language
- ISSN
- 1359-6349